Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.47 |
| ▸ | LSS | P48449 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.42 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.42 |
| ▸ | HTR3A | P46098 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8025867 | 1.00 | CYP2C9 (0.59) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8398937 | 0.95 | CYP2C9 (0.55) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL17552974 | 0.95 | CYP2C9 (0.55) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL7510559 | 0.95 | CYP2C9 (0.55) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8398929 | 0.95 | CYP2C9 (0.55) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8448301 | 0.93 | CYP2C9 (0.54) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8448306 | 0.93 | CYP2C9 (0.54) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8448309 | 0.93 | CYP2C9 (0.54) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8377290 | 0.92 | CYP2C9 (0.52) | CYP2C9DRD2MEN1KMT2AALDH1A1 | |
| SCHEMBL8377293 | 0.92 | CYP2C9 (0.52) | CYP2C9DRD2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 251 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-58079938-A | — | — | None | — | — | JP | disclosed |
| JP-8073857-A | — | — | None | — | — | JP | disclosed |
| EP-3331965-B1 | LIQUID CRYSTAL MEDIUM | MERCK PATENT GMBH (DE) | 2022-01-05 | — | — | EP | disclosed |
| US-20210214615-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT | JNC CORPORATION (JP) | 2021-07-15 | — | — | US | disclosed |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | JNC CORPORATION (JP) | 2020-12-15 | — | — | US | disclosed |
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | JNC CORPORATION (JP) | 2020-09-29 | — | — | US | disclosed |
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-09-24 | — | — | US | disclosed |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | JNC CORPORATION (JP) | 2020-09-01 | — | — | US | disclosed |
| EP-3656757-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2020-05-27 | — | — | EP | disclosed |
| US-10662379-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2020-05-26 | — | — | US | disclosed |
| JP-H0873857-A | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT | CHISSO CORP | 1996-03-19 | — | — | JP | disclosed |
| EP-0688754-A1 | DICYCLOHEXYLETHYLENE DERIVATIVE | CHISSO CORPORATION (JP) | 1995-12-27 | — | — | EP | disclosed |
| US-5456860-A | Containing liquid crystal mixture based on dielectrically positive compounds which contain polar end group with specified lipophilicity parameter | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-10-10 | — | — | US | disclosed |
| EP-0640578-A1 | Novel liquid crystalline compound having a 1,1,2,3,3,3,-hexafluoropropyl group and liquid crystal composition | Chisso Corporation (JP) | 1995-03-01 | — | — | EP | disclosed |
| US-5389289-A | Chemical and heat resistance | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1995-02-14 | — | — | US | disclosed |
| EP-0450354-A2 | Matrix-liquid crystal display | MERCK PATENT GmbH (DE) | 1991-10-09 | — | — | EP | disclosed |
| EP-0074608-B1 | LIQUID CRYSTAL HALOGEN COMPOUNDS, PROCESS FOR THEIR PREPARATION, DIELECTRIC AND DECTROOPTICAL DISPLAY ELEMENT CONTAINING THEM | MERCK PATENT GmbH (DE) | 1985-07-03 | — | — | EP | disclosed |
| US-4490305-A | Liquid-crystalline halogen compounds, process for their preparation, dielectrics containing these, and electro-optical display element | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-12-25 | — | — | US | disclosed |
| JP-S5879938-A | 4-(TRANS-4'-ALKYLCYCLOHEXYL)-CHLOROBENZENE | ASAHI GLASS CO LTD | 1983-05-13 | — | — | JP | disclosed |
| EP-0074608-A2 | Liquid crystal halogen compounds, process for their preparation, dielectric and dectrooptical display element containing them | MERCK PATENT GmbH (DE) | 1983-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10787608-B2 | Liquid crystal display device including liquid crystal medium containing low molecular weight polar compound for homogeneously aligning liquid crystal medium | ACP1, MAPK1, PLD1 | CYP2C9 3583/4885DRD2 1233/4885MEN1 356/4885 |
| US-10662379-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display device | SP1, MBD2, PAXBP1 | CYP2C9 3761/4885DRD2 127/4885MEN1 73/4885 |
| US-10759998-B2 | Polymerizable polar compound, liquid crystal composition and liquid crystal display element | SP1, SFXN3, SFXN1 | CYP2C9 4664/4885DRD2 891/4885MEN1 1020/4885 |
| US-10865344-B2 | Low molecular weight polar compound for homogeneously aligning liquid crystal medium, and liquid crystal medium containing same | ACP1, MFAP1, PHOSPHO1 | CYP2C9 4617/4885DRD2 3943/4885MEN1 232/4885 |
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, CCND1, CPNE4 | CYP2C9 3951/4885DRD2 71/4885MEN1 1010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.